Tonix Pharma's total assets for Q2 2025 were $187.36M, a decrease of -2.86% from the previous quarter. TNXP total liabilities were $19.36M for the fiscal quarter, a 55.19% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.